“I was told by someone ... that the contractor for the CDC and the FDA on VAERS identified a [myocarditis] signal in February ,” shared Dr. @NassMeryl.
“Everybody in Israel knew about it. But CDC and FDA ... kept it under wraps until they could get an approval to give the vaccine to exactly the age group [adolescents] that was at highest risk of myocarditis. So this is malfeasance, I would say.”
*The opinions expressed by the hosts and guests in this show are not necessarily the views of Children’s Health Defense.